Reproductive Health News

After using smartphone-based multimedia educational aids about preterm birth, pregnant women reported they were more knowledgeable, less anxious and better prepared for decision-making about maternal and infant health, study results show.

Women who attempted self-managed medication abortion from 9 to 16 weeks gestation experienced high completion rates, with 23.5% visiting health care professionals to confirm completion or treat complications, researchers reported.

The FDA approved zuranolone as the first oral treatment for postpartum depression in adults, according to an agency press release.

Breastfeeding is different for every new mother, and the most important aspect is making sure the mother has all the knowledge and support needed to successfully breastfeed her newborn.

Publication of trial results showing reduced cesarean birth and hypertensive disorders of pregnancy risks with elective labor induction was associated with a rise in elective labor induction for singleton, nulliparous pregnancies.

Women physicians reported that career-related pressures influence pregnancy timing, affect infertility rates and result in career trajectory changes to accommodate family building and parenthood, according to survey results.

The proportion of girls diagnosed with rapidly progressive central precocious puberty increased after the start of the COVID-19 pandemic compared with before the pandemic, according to a study conducted in Italy.

Women with intrahepatic cholestasis of pregnancy delivered earlier and had a lower percentage of stillbirths compared with women without the liver disorder, researchers reported in the American Journal of Obstetrics & Gynecology.

The investigational neuroactive steroid zuranolone was generally well-tolerated and demonstrated significant improvement in symptoms in women with postpartum depression, according to a study published in The American Journal of Psychiatry.

Individuals who are planning to or could become pregnant should take a daily folic acid supplementation of 0.4 to 0.8 mg to prevent neural tube defects, according to a final recommendation from the U.S. Preventive Services Task Force.